Monoclonal antibodies against MERS coronavirus show promise in Phase 1 NIH-sponsored trial | National Institutes of Health (NIH)

Monoclonal antibodies against MERS coronavirus show promise in Phase 1 NIH-sponsored trial | National Institutes of Health (NIH): Antibodies were well tolerated and generally safe when administered simultaneously to healthy adults.